A retrospective, observational, multicenter study of Maraviroc plus Protease Inhibitor in HIV infected patients who switched to double therapy.
Phase of Trial: Phase IV
Latest Information Update: 01 Mar 2016
At a glance
- Drugs HIV protease inhibitors (Primary) ; Maraviroc (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- 01 Mar 2016 New trial record